The treatment for RS3PE is oral steroids with a typical starting dose of 10–20 mg of prednisone per day with a rapid response within days. Prognosis is reported to be good, although many patients are still requiring low-dose oral steroids and/or disease-modifying anti- rheumatic drugs such as methotrexate a year or more after diagnosis.

Cases. DermNet now features a library of authentic patient cases with images. These cover the various symptoms, diagnosis, treatments, and outcomes that can be expected in the real world.